Surgical Quality Improvement

Dermatology & Plastic Surgery Institute Outcomes

Dermatology & Plastic Surgery Institute Surgery ACS NSQIP Outcomes

January 1, 2020 – December 31, 2020

The American College of Surgeons National Surgical Quality Improvement Program (ACS NSQIP®) objectively measures and reports risk-adjusted surgical outcomes based on a defined sampling and abstraction methodology. These outcomes data reflect Cleveland Clinic’s Dermatology & Plastic Surgery Institute surgery ACS NSQIP performance benchmarked against 457 participating sites.

Dermatology & Plastic Surgery (457 Sites)NObservedExpected
30 Day Morbidity3274.89%5.27%
Cardiac 3270.00%0.02%
Pneumonia3270.00%0.10%
Unplanned Intubation3270.00%0.04%
Ventilator > 48 Hours3270.00%0.02%
Urinary Tract Infection (UTI)3270.00%0.13%
Surgical Site Infection (SSI)3274.89%4.10%
Sepsis3270.31%0.21%
Return to Operating Room (ROR)3277.03%5.15%
Readmission 3273.98%2.95%

American College of Surgeons National Surgical Quality Improvement Program, 2021.
ACS NSQIP® Semiannual Report July 8, 2021, Chicago: American College of Surgeons.

In addition to overall dermatology & plastic surgery ACS NSQIP® outcomes data, data specific to breast reconstruction is provided. Breast reconstruction performance is benchmarked against 357 participating sites.